Additionally, thioredoxin activates ribonucleotide reductase, inhibits apoptosis signal regulating kinase 1, and induces HIF-1 and vascular endothelial growth factor (VEGF), contributing to cancer traits such as increased proliferation, inhibited apoptosis, and angiogenesis. This evidence concerns the gene VEGFA and cancer.